Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

Pablo Aschner; Juliana Chan; David R Owens; Sylvie Picard; Edward Wang; Marie-Paule Dain; Valérie Pilorget; Akram Echtay; Vivian Fonseca

doi:10.1016/s0140-6736(12)60439-5

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

The Lancet ◽

10.1016/s0140-6736(12)60439-5 ◽

2012 ◽

Vol 379 (9833) ◽

pp. 2262-2269 ◽

Cited By ~ 74

Author(s):

Pablo Aschner ◽

Juliana Chan ◽

David R Owens ◽

Sylvie Picard ◽

Edward Wang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Open Label ◽

Open Label Trial

Download Full-text

Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2)

Advances in Therapy ◽

10.1007/s12325-021-01631-y ◽

2021 ◽

Author(s):

Tomoyuki Katsuno ◽

◽

Toshihiko Shiraiwa ◽

Shingo Iwasaki ◽

Hyohun Park ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Open Label ◽

Randomized Controlled ◽

Open Label Trial

Download Full-text

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

Drugs in R&D ◽

10.1007/s40268-016-0134-z ◽

2016 ◽

Vol 16 (2) ◽

pp. 239-249 ◽

Cited By ~ 13

Author(s):

Changyu Pan ◽

Jorge L. Gross ◽

Wenying Yang ◽

Xiaofeng Lv ◽

Li Sun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Degludec ◽

Treat To Target ◽

Target Trial ◽

Open Label

Download Full-text

Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus®) in Chinese adults with type 2 diabetes mellitus: A Phase III , randomised, open‐label, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14392 ◽

2021 ◽

Author(s):

Wenhuan Feng ◽

Wei Chen ◽

Shan Jiang ◽

Liying Du ◽

Dalong Zhu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Chinese Adults ◽

Open Label

Download Full-text

Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.01.035 ◽

2019 ◽

Vol 150 ◽

pp. 331-341 ◽

Cited By ~ 8

Author(s):

Mohamed M. Hassanein ◽

Rakesh Sahay ◽

Khadija Hafidh ◽

Khier Djaballah ◽

Haoyu Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Insulin Treatment ◽

Open Label ◽

Open Label Trial

Download Full-text

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13506 ◽

2018 ◽

Vol 21 (2) ◽

pp. 234-243 ◽

Cited By ~ 16

Author(s):

Weiqing Wang ◽

Luis Nevárez ◽

Ekaterina Filippova ◽

Ki Ho Song ◽

Bei Tao ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Asian Patients

Download Full-text

An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes Mellitus

Internal Medicine ◽

10.2169/internalmedicine.54.3993 ◽

2015 ◽

Vol 54 (13) ◽

pp. 1591-1598 ◽

Cited By ~ 1

Author(s):

Ippei Kanazawa ◽

Masakazu Notsu ◽

Ken-ichiro Tanaka ◽

Nobuaki Kiyohara ◽

Yuko Tada ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Longitudinal Study ◽

Insulin Glargine ◽

Open Label

Download Full-text

New insulin glargine 300 U/mL: glycaemic control and hypoclycaemia in insulin-naïve people with type 2 diabetes mellitus (EDITION 3)

Diabetologie und Stoffwechsel ◽

10.1055/s-0035-1549678 ◽

2015 ◽

Vol 10 (S 01) ◽

Author(s):

M Ziemen ◽

MC Riddle ◽

RM Bergenstal ◽

K Sestakauskas ◽

H Goyeau ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Insulin Glargine

Download Full-text

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db19-1068-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1068-P

Author(s):

LIMING CHEN ◽

LINONG JI ◽

YANGANG WANG ◽

ZHONGSHU MA ◽

XINGWU RAN ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Safety Profile ◽

Chinese Patients ◽

Open Label ◽

Parallel Group ◽

Free Insulin

Download Full-text

Clinical Research of Insulin Glargine U300 basal‐bolus therapy and Insulin Degludec/Aspart Co‐Formulation in Type 2 Diabetes Mellitus: A Real World Experience (CRIGDA Study)

International Journal of Clinical Practice ◽

10.1111/ijcp.14377 ◽

2021 ◽

Author(s):

Savas Volkan Kisioglu ◽

Ahmet Suat Demir ◽

Damla Tufekci ◽

Yasemin Emur Gunay ◽

Hulya Coskun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Research ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Basal Bolus

Download Full-text

RESVERATROL SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL

International Research Journal of Pharmacy ◽

10.7897/2230-8407.04849 ◽

2013 ◽

Vol 4 (8) ◽

pp. 245-249 ◽

Cited By ~ 20

Author(s):

Jayesh Kumar Bhatt ◽

Moola Joghee Nanjan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Open Label ◽

Randomized Controlled

Download Full-text